Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate pharmacokinetics, safety, and efficacy during pregnancy in women with ADHD
NL-OMON49916Completed
- Sponsor
- Isala
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Isala. Primary endpoint: Serum methylphenidate levels. Started Aug 2022; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NL-OMON49916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49916.